Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Merck & Co., Inc.    MRK   US58933Y1055

MERCK & CO., INC.

 (MRK)
59
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/13/2013 06/14/2013 06/17/2013 06/18/2013 06/19/2013 Date
47.9(c) 47.95(c) 47.8(c) 47.75(c) 47.58(c) Last
14 775 462 13 633 687 12 485 297 11 823 666 18 000 478 Volume
+1.38% +0.10% -0.31% -0.10% -0.36% Change
More quotes
Company
Merck and Company specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (67.1%): for treating hypertension, osteoporosis, atherosclerosis, respiratory,... 
Read more
Surperformance© rating of Merck & Co., Inc.
Trading Rating : Investor Rating :
More about the company
Chart MERCK & CO., INC.
Duration : Period :
Merck & Co., Inc. Technical Analysis Chart | MRK | US58933Y1055 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 45 111 M
EBIT 2013 13 865 M
Net income 2013 6 814 M
Finance 2013 1 851 M
Yield 2013 3,60%
Sales 2014 45 734 M
EBIT 2014 14 452 M
Net income 2014 8 908 M
Finance 2014 8 511 M
Yield 2014 3,70%
PER 2013 21,53
PER 2014 16,56
EV / Sales 2013 3,14x
EV / Sales 2014 2,96x
Capitalization 143 673 M
More Financials
Latest news on MERCK & CO., INC.
1d agoDJBristol, AstraZeneca Diabetes Drug Fails to Cut Heart Risk
2d agoDJREDHILL BIOPHARMA: FDA Sets Feb. 3 Goal Date to Review Generic Maxalt Applicati..
6d agoDJMERCK & CO., INC.: Merck R&D Job Cuts Strip Layer of Senior Management
6d agoDJMerck Shakes Up Drug Research Unit, Plans Job Cuts
6d agoDJMerck Shakes Up Drug Research Unit, Plans Job Cuts
7d agoDJLilly Ends Alzheimer's Drug Study On Safety Concern
06/13 MERCK & CO: ex-dividend day
06/12DJMerck Backs Call for Independent Review of Diabetes Treatments
06/12DJMerck Backs Call for Independent Review of Diabetes Treatments
06/12 MERCK & CO., INC.: Merck Welcomes Independent Review of the Safety Profile of J..
06/06DJImmunotherapy Cancer Drug Race Speeds Up After Medical Meeting
06/06DJImmunotherapy Cancer Drug Race Speeds Up After Medical Meeting
More news
Forum MERCK & CO., INC.
Be the first to post a message on MERCK & CO., INC.
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
Merck _ Co., Inc. : Income Statement Evolution
More Financials
EPS Revisions
Merck _ Co., Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Stay Connected :
Copyright © 2013 Surperformance. All rights reserved.